指南与共识肺结节与肺癌

LUCiD:澳大利亚与新西兰胸科肿瘤临床质量指标的改良eDelphi共识

Lung cancer (internet-based) Delphi (LUCiD): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancer.
指南 / 共识 · Respirology · 2024-08-13

该研究通过文献综述和改良三轮eDelphi共识流程,由多学科临床医生、患者倡导者等参与,在澳大利亚和新西兰建立了胸科肿瘤临床质量指标。文献综述识别422项国际指标,评估71项,最终27项达成共识,涵盖从诊断到一线治疗的诊疗全程,并制定了配套数值质量标准。

要点

  • 建立了27项胸科肿瘤临床质量指标,覆盖诊断至一线治疗全程。
  • 共识阈值设为70%,经三轮eDelphi流程(两轮在线问卷、一轮混合会议)达成。
  • 支持性护理相关指标代表性不足,需后续补充完善。

核心结论

  • 形成了27项适用于澳大利亚和新西兰胸科肿瘤诊疗的临床质量指标,并制定了配套数值质量标准以支持基准比对。

研究设计与样本

  • 共识阈值设定为70%;前两轮为在线问卷,最后一轮为线下与线上混合共识会议。
  • 文献综述识别了422项国际胸科肿瘤学指标,共评估71项指标。

主要发现

  • 最终27项临床质量指标达成共识,覆盖从诊断到一线治疗的胸科肿瘤诊疗全程。
  • 支持性护理领域的基准指标代表性不足。
  • 为便于基准比对,制定了配套的数值质量标准。

关键数值与推荐

  • 共识阈值:70%。
  • 文献综述识别422项国际胸科肿瘤学指标,评估71项,最终27项达成共识。

临床怎么用

  • 可用于澳大利亚和新西兰胸科肿瘤诊疗的临床质量基准比对。
  • 配套数值质量标准有助于评估和改善诊疗服务。
  • 支持性护理指标不足,临床应用中需注意该领域覆盖有限。

局限性

  • 支持性护理相关基准指标代表性不足。
  • 研究区域限于澳大利亚和新西兰,外推需谨慎。
  • 真实世界实施仍需利用澳大利亚前瞻性数据集进一步探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Approximately 16,000 new cases of lung cancer are diagnosed each year in Australia and Aotearoa New Zealand, and it is the leading cause of cancer death in the region. Unwarranted variation in lung cancer care and outcomes has been described for many years, although clinical quality indicators to facilitate benchmarking across Australasia have not been established. The purpose of this study was to establish clinical quality indicators applicable to lung and other thoracic cancers across Australia and Aotearoa New Zealand. METHODS: Following a literature review, a modified three round eDelphi consensus process was completed between October 2022 and June 2023. Participants included clinicians from all relevant disciplines, patient advocates, researchers and other stakeholders, with representatives from all Australian states and territories and Aotearoa New Zealand. Consensus was set at a threshold of 70%, with the first two rounds conducted as online surveys, and the final round held as a hybrid in person and virtual consensus meeting. RESULTS: The literature review identified 422 international thoracic oncology indicators, and a total of 71 indicators were evaluated over the course of the Delphi consensus. Ultimately, 27 clinical quality indicators reached consensus, covering the continuum of thoracic oncologic care from diagnosis to first line treatment. Indicators benchmarking supportive care were poorly represented. Attendant numeric quality standards were developed to facilitate benchmarking. CONCLUSION: Twenty-seven clinical quality indicators relevant to thoracic oncology care in Australasia were developed. Real world implementation will now be explored utilizing a prospective dataset collected across Australia.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Nash J, Stone E, Vinod S, et al. Lung cancer (internet-based) Delphi (LUCiD): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancer. Respirology. 2024. PMID: 39138009. doi:10.1111/resp.14812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。